• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Company Study of Changzhou Tiansheng New Materials Co., Ltd., 2011 (Chinese Version)

  • ID: 2121912
  • May 2012
  • 9 pages
  • Research In China

Changzhou Tiansheng New Materials Co., Ltd. (Tiansheng, stock code: 300169) was established in July 1998 and went public in A Share of Shenzhen Stock Exchange in January 2011, with the registered capital of RMB140.25 million. Its website is http://www.tschina.com.

Tiansheng commits itself to research, development, production and sale of high-polymer foam materials. It is a leader in flexible foam, structural foam and post-processing fields. It has three wholly-owned subsidiaries, one holding subsidiary and three sub-subsidiaries.

Note: Product cover images may vary from those shown

1. Profile
2. Operation
3. Flexible Foam Materials
4. Structural Foam Materials
5. 4kt/a Structural Foam Material of Tiansheng New Material Expected to be Put into Operation in Jun. 2012

Selected Charts

Operating Revenue and Total Profit of Changzhou Tiansheng New Materials, 2008-2011
Operating Revenue Structure of Changzhou Tiansheng New Materials by Product, 2009-2011H1
Gross Margin of Changzhou Tiansheng New Materials by Product, 2010-2011H1
Operating Revenue of Changzhou Tiansheng New Materials by Region, 2009-2011H1
Operating Revenue, Operating Cost and Gross Margin of Flexible Foam Materials of Changzhou Tiansheng New Materials, 2009-2011H1 (Unit: RMB mln)
Output and Market Shares of Flexible Foam Plastics of Changzhou Tiansheng New Materials, 2007-2010H1 (Unit: 1,000 m3)
Output and Market Shares of Flexible Foam Rubbers of Changzhou Tiansheng New Materials, 2007-2010H1 (Unit: 1,000 m3)
Operating Revenue, Operating Cost and Gross Margin of Structural Foam Materials of Changzhou Tiansheng New Materials, 2009-2011H1 (Unit: RMB mln)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

ALSO AVAILABLE IN THE FOLLOWING LANGUAGES

RELATED PRODUCTS

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.